U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Endometrioid Adenocarcinoma

MedGen UID:
1681556
•Concept ID:
C0862493
•
Neoplastic Process
Synonyms: Recurrent Endometrial Adenocarcinoma; Recurrent Endometrial Adenocarcinoma, Not Otherwise Specified

Definition

The reemergence of endometrial adenocarcinoma after a period of remission. [from NCI]

Professional guidelines

PubMed

The promise of combining CDK4/6 inhibition with hormonal therapy in the first-line treatment setting for metastatic or recurrent endometrial adenocarcinoma.
Ray-Coquard I, Monk BJ, Lorusso D, Mahdi H, Upadhyay V, Graul R, Husain A, Mirza MR, Slomovitz B
Int J Gynecol Cancer 2023 Dec 4;33(12):1943-1949. doi: 10.1136/ijgc-2023-004739. PMID: 37907262Free PMC Article

Recent clinical studies

Diagnosis

The promise of combining CDK4/6 inhibition with hormonal therapy in the first-line treatment setting for metastatic or recurrent endometrial adenocarcinoma.
Ray-Coquard I, Monk BJ, Lorusso D, Mahdi H, Upadhyay V, Graul R, Husain A, Mirza MR, Slomovitz B
Int J Gynecol Cancer 2023 Dec 4;33(12):1943-1949. doi: 10.1136/ijgc-2023-004739. PMID: 37907262Free PMC Article

Therapy

The promise of combining CDK4/6 inhibition with hormonal therapy in the first-line treatment setting for metastatic or recurrent endometrial adenocarcinoma.
Ray-Coquard I, Monk BJ, Lorusso D, Mahdi H, Upadhyay V, Graul R, Husain A, Mirza MR, Slomovitz B
Int J Gynecol Cancer 2023 Dec 4;33(12):1943-1949. doi: 10.1136/ijgc-2023-004739. PMID: 37907262Free PMC Article
Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma.
Ramondetta LM, Johnson AJ, Sun CC, Atkinson N, Smith JA, Jung MS, Broaddus R, Iyer RB, Burke T
Cancer 2009 May 1;115(9):1867-74. doi: 10.1002/cncr.24197. PMID: 19241422

Prognosis

Cushing's syndrome associated with recurrent endometrioid adenocarcinoma of the ovary.
Crawford SM, Pyrah RD, Ismail SM
J Clin Pathol 1994 Aug;47(8):766-8. doi: 10.1136/jcp.47.8.766. PMID: 7962637Free PMC Article

Clinical prediction guides

Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma.
Ramondetta LM, Johnson AJ, Sun CC, Atkinson N, Smith JA, Jung MS, Broaddus R, Iyer RB, Burke T
Cancer 2009 May 1;115(9):1867-74. doi: 10.1002/cncr.24197. PMID: 19241422

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...